400-888-1571 首页 购物车
Expert Opinion On Therapeutic Targets

Expert Opinion On Therapeutic Targets

治疗靶点专家意见

  • 2区 中科院分区
  • Q1 JCR分区
期刊首页 期刊评价 发文分析 高引用文章 了解投稿 期刊咨询

期刊简介

《Expert Opinion On Therapeutic Targets》是由Taylor and Francis Ltd.出版社于2001年创办的英文国际期刊（ISSN: 1472-8222，E-ISSN: 1744-7631），该期刊长期致力于药学领域的创新研究，主要研究方向为医学-药学。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA未开放获取模式（OA占比0.0027...%），以发表药学领域等方向的原创性研究为核心（研究类文章占比23.66%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在93篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Expert Opinion On Therapeutic Targets审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单，年发文量约93篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 否 是否预警
  • SCIE 期刊收录
  • 93 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
否 是
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
否 是
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科：PHARMACOLOGY & PHARMACY SCIE Q1 57 / 354

84%
按JCI指标学科分区 收录子集 分区 排名 百分位
学科：PHARMACOLOGY & PHARMACY SCIE Q2 125 / 354

64.83%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore：8.9 SJR：1.423 SNIP：0.975
学科类别 分区 排名 百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology Q1 52 / 313

83%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery Q1 29 / 157

81%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Clinical Biochemistry Q1 23 / 117

80%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Molecular Medicine Q1 43 / 178

76%

期刊发文

  • Targeting endoplasmic reticulum stress-the responder to lipotoxicity and modulator of non-alcoholic fatty liver diseases

    Author: Luo, Yu; Jiao, Qiangqiang; Chen, Yuping

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14728222.2022.2170780

  • The participation of non-canonical autophagic proteins in the autophagy process and their potential as therapeutic targets

    Author: Yin, Yiming; Zhou, Yourong; Yang, Xiaochun; Xu, Zhifei; Yang, Bo; Luo, Peihua; Yan, Hao; He, Qiaojun

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14728222.2023.2177151

  • Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation

    Author: Huang, Yanjie; Zhao, Xueru; Zhang, Qiushuang; Yang, Xiaoqing; Hou, Gailing; Peng, Chaoqun; Jia, Mengzhen; Zhou, Li; Yamamoto, Tatsuo; Zheng, Jian

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14728222.2023.2177534

  • Recent advances of Phosphodiesterase 4B in cancer

    Author: Miao, Yu; Peng, Li; Chen, Zhaolin; Hu, Ying; Tao, Liangsong; Yao, Yan; Wu, Yincui; Yang, Dashuai; Xu, Tao

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. 27, Issue 2, pp. 121-132. DOI: 10.1080/14728222.2023.2183496

  • Papain exerts an anti-atherosclerosis effect with suppressed MPA-mediated foam cell formation by regulating the MAPK and PI3K/Akt-NF-kappa B pathways

    Author: Fei, Xianming; Pan, Lianlian; Yuan, Wufen; Zhao, Yan; Jiang, Lei; Huang, Qinghua; Wu, Yan; Ru, Guoqing

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. 27, Issue 3, pp. 239-250. DOI: 10.1080/14728222.2023.2194531

  • Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection

    Author: Xie, Bo; Zhu, Yuqi; Shen, Yuqing; Xu, Wen; Song, Xiuzu

    Journal: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023; Vol. 27, Issue 3, pp. 189-206. DOI: 10.1080/14728222.2023.2193329

  • Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung.

    Author: Zhang B1,2, Ma Z1, Tan B1, Lin N1,2.

    Journal: Expert Opin Ther Targets. 2019 Mar;23(3):241-250. doi: 10.1080/14728222.2019.1559824. Epub 2018 Dec 27.

  • The P2X7 receptor: a new therapeutic target in Alzheimer's disease.

    Author: Illes P1,2, Rubini P2, Huang L2, Tang Y2.

    Journal: Expert Opin Ther Targets. 2019 Mar;23(3):165-176. doi: 10.1080/14728222.2019.1575811.

相关期刊

怎样选择期刊
投稿相关问题
投稿后咨询